Our experiments also indicate that OXT is downstream of MYT1L. This suggests that loss of OXT may be a final common pathway in genetic forms of obesity, and represent a treatment target in multiple disorders. Here, OXT is linked to obesity due to melanocortin 4 receptor deficiency.